Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 August, 2017 10:51 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Dr Reddy's to get up to USD 32.5 mn in milestone payments for DFD-06 - 22-Aug-2017 10:33
Eros International Media's promoter completes sale of 11.8 mn shares - 22-Aug-2017 10:22
ONGC receives nod to acquire government's 51.11% stake in HPCL - 22-Aug-2017 10:19
ONGC receives nod to acquire government's 51.11% stake in HPCL - 22-Aug-2017 10:19
HCL Infosystems to distribute Apple products in Indian market - 22-Aug-2017 10:05
Lupin receives EIR from USFDA for Aurangabad facility - 22-Aug-2017 10:02
McNally Bharat bags order worth Rs 5.14 bn - 22-Aug-2017 09:58
TCS' arm to deploy digital learning platform for ICSI - 21-Aug-2017 16:09
Jubilant receives NDA approval for Drax Exametazime - 21-Aug-2017 15:07
Tata Power launches electric vehicle charging infrastructure in Mumbai - 21-Aug-2017 13:54
Blue Star wins multiple MEP orders of over Rs 5 bn - 21-Aug-2017 12:03
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer